As contagious bovine pleuropneumonia (CBPP) is spreading fast in many African countries, there is an increasing demand for rapid and sensitive diagnostic methods that can be used to confirm the initial diagnosis based on clinical symptoms or pathological findings. Two PCR-based diagnostic systems for identification of the infectious agent, Mycoplasma mycoides subsp. mycoides SC (M. mycoides SC), in various samples are presented. Both systems involve group-specific amplification of the two 16S rRNA genes from mycoplasmas of the M. mycoides cluster. The laser-induced fluorescence assay is based on a unique sequence length difference between the two 16S rRNA genes in M. mycoides SC. This region was amplified by PCR, and the products were separated by polyacrylamide gel electrophoresis in a DNA sequencer. The resulting electropherogram showed two peaks for strains of M. mycoides SC and one peak for all other members of the M. mycoides cluster. The second system was based on restriction endonuclease analysis and agarose gel electrophoresis. Restriction of amplicons from a region containing a polymorphism, which is found in M. mycoides SC only, resulted in an extra band on the agarose gel because an AluI site is lacking in the rrnA operon. Specimens from cows with postmortem signs of CBPP were analyzed with the two PCR systems. M. mycoides SC was clearly identified in pleural fluid and lung tissue, and the methods were found to be robust and rapid. The results were in agreement with those obtained by conventional diagnostic techniques.
Contagious bovine pleuropneumonia (CBPP) is a severe respiratory disease affecting cattle. The symptoms range from hyperacute through acute to chronic and subclinical forms (10) . Clinical signs of the acute form involve cessation of rumination, nasal discharge, a dry cough, and difficulty in breathing (27, 28) . The rate of mortality in affected cattle is low in Europe, while in Africa CBPP causes more losses than any other cattle disease and the mortality rate varies from 10 to 70% (2, 10, 17) . CBPP is present in 24 countries of tropical Africa, and the disease has been reported to spread very fast in the eastern and southeastern countries (14) . In Europe, sporadic outbreaks of CBPP occur in the regions of endemicity in northwestern Portugal, and one or more outbreaks have been recorded yearly in Spain since 1991 (10, 23) .
Mycoplasma mycoides subsp. mycoides SC (M. mycoides SC), the infectious agent of CBPP, was first isolated and described by Nocard and Roux in 1898 (18) . Nearly 60 years later the organism was identified as a mycoplasma, and it was given its present name (9) . Phylogenetic classification has grouped M. mycoides SC into the Mycoplasma mycoides cluster of the spiroplasma group, together with eight closely related mycoplasmas: Mycoplasma capricolum subsp. capricolum, Mycoplasma capricolum subsp. capripneumoniae, Mycoplasma mycoides subsp. mycoides type LC, Mycoplasma mycoides subsp. capri, Mycoplasma sp. bovine group 7, Mycoplasma cottewii, Mycoplasma yeatsii, and Mycoplasma putrefaciens (12, 21, 29) . The latter three species are not included in the classical M. mycoides cluster. Mycoplasma sp. bovine group L (1) is believed to belong to the classical M. mycoides cluster.
The species within the classical M. mycoides cluster are difficult to distinguish by morphological and biochemical analyses. Many diagnostic methods for CBPP are based on serological reactions like those in enzyme-linked immunosorbent assays (ELISA), complement fixation tests, immunohistochemical tests, and protein immunoblotting, methods which can be time-consuming and some of which are not sufficiently specific or sensitive (7, 16) . Furthermore, recent reports on variable surface proteins of mycoplasmas indicate that ambiguous results may occur when monospecific antibodies are used in diagnostics based on antigen detection (25, 26, 30) .
PCR has the advantage of being a fast, specific, and very sensitive technique. Most of the diagnostic PCR systems which are used today (3, 8, 13, 15) are designed to target the CAP-21 gene, whose gene product has an unknown function. Alternative diagnostic PCR systems based on other parts of the genome can be useful. The 16S rRNA genes provide well-examined sequences with segments of different evolutionary variability, which are ideal target regions for primers in groupspecific or species-specific amplification. Mycoplasmas belonging to the M. mycoides cluster have two rRNA operons (20) . Species identification based on PCR of the 16S rRNA genes and restriction in positions where unique differences (polymorphisms) occur between the two operons has been demonstrated previously for M. capricolum subsp. capripneumoniae (24) .
This study comprises the design and evaluation of two diagnostic systems based on PCR of the 16S rRNA genes. The aim of the first system was to achieve a highly sensitive PCR which would be suitable for large-scale diagnostic screening. The aim Diagnosis by PCR-REA. The PCR for subsequent restriction endonuclease analysis (REA) amplifies a segment in the 16S rRNA genes of the rrnA and the rrnB operons for species belonging to the classical M. mycoides cluster. The forward primer F-REAP targets the variable region V2, and the reverse primer R-REAP is complementary to the universal region U5 in the 16S rRNA genes. Oligonucleotide sequences and positions are listed in Table 2 . All amplifications were performed in a reaction mixture consisting of 50 mM KCl, 4 mM MgCl 2 , 10 mM Tris-HCl buffer (pH 8.3), 0.8 mM dNTP, 5 pmol of each primer, and 0.6 U of AmpliTaq DNA polymerase in a total volume of 50 l. Target DNA was either 5 ng of pure genomic DNA, 1 l of a heat-lysed cell suspension, 1 l of a pleural-fluid suspension, or 500 ng of a lung tissue preparation. PCR was performed in a Techne Thermocycler for 33 cycles of denaturation at 96°C for 30 s, annealing at 60°C for 30 s, and extension at 72°C for 1 min. The reaction mixtures were preheated to 96°C for 3 min in order to complete denaturation before the first primer annealing step, and the final extension step was kept at 72°C for 5 min. To differentiate M. mycoides SC from the other members of the classical M. mycoides cluster, the PCR product was digested with AluI (Promega Corporation, Madison, Wis.). Restriction was performed in 0.7ϫ B buffer (1ϫ B buffer contains 6 mM Tris-HCl [pH 7.5], 6 mM MgCl 2 , 50 mM NaCl, and 1 mM dithiothreitol) and bovine serum albumin (0.1 mg/ml) with 5 U of the enzyme for a 20-l reaction volume, and the mixtures were incubated at 37°C for at least 1 h. The samples were analyzed by agarose gel electrophoresis in 3.2% MetaPhor Agarose (FMC BioProducts, Rockland, Maine).
RESULTS
Sequence analysis of the 16S rRNA genes. DNA sequencing of 25 M. mycoides SC strains and one of the pleural-fluid samples from Tanzania showed that all strains have identical 16S rRNA genes with two exceptions: the type strain PG1, which had a G/T polymorphism in position 887, where the other strains had guanosines in the two genes, and the Tanzanian field sample, which had a G/T polymorphism in position 829, which normally contains guanosines in both operons. All nucleotide positions are numbered according to the consensus sequence of the 16S rRNA genes of the members of the M. mycoides cluster (22) . As reported earlier, the 16S rRNA genes of the PG1 T strain has a total of eight polymorphisms and a 2-bp sequence length difference between the genes (22) .
Importantly, all sequenced strains contained the poly(A) region where the rrnA has 5 adenosines and the rrnB has 7 adenosines, which is the basis for discrimination of M. mycoides SC with the PCR-LIF system. Also the T/G polymorphism in position 426, which is discriminatory in the PCR-REA system, was found in all analyzed strains. There were no variations in the primer target sequences for the analyzed M. mycoides SC strains.
Diagnostic system based on PCR-LIF. Amplification by the PCR-LIF system resulted in two different amplicons of 127 and 129 bp for all M. mycoides SC strains that were included in the study. These DNA fragments were clearly detected as two peaks in the electropherogram of the sequencer (Fig. 1) However, none of these species contain the insertion and deletion in the poly(A) region between positions 1264 and 1270, and accordingly, equal-sized fragments of 128 bp were produced from the two genes (Fig. 1) putrefaciens, and M. yeatsii, which all belong to the phylogenetic M. mycoides cluster, were amplified when concentrated template preparations were added to the reaction mixture. The amounts of the PCR products from these species were considerably lower than that of any species of the classical M. mycoides cluster, and they all generated single peaks corresponding to 128 bp in the electropherogram. A mixture of M. mycoides SC and another mycoplasma of the M. mycoides cluster resulted in a misshaped peak upon electrophoresis, but the resolution was too poor to allow separation of the fragments into three distinct entities (data not shown).
The sensitivity of the assay was determined on two different dilution series of culture from strain PG1
T . Amplification of a 1-l suspension from each fraction in either of the dilution series resulted in a detection level corresponding to 0.3 or 0.4 CFU, respectively.
Diagnostic system based on PCR-REA. Each strain of the classical M. mycoides cluster that was amplified with the REAP primers generated a 785-bp fragment by PCR (Fig. 2A) . Further processing of the amplicon by restriction with AluI distinguished M. mycoides SC from the other species. M. mycoides SC has a unique polymorphism located at position 426 of the 16S rRNA gene. The rrnA operon, which has thymidine instead of guanosine in this position, lacks one of the AluI restriction sites. Consequently, AluI restriction of amplicons from M. mycoides SC gives a 370-bp fragment in addition to the 236-, 186-, 184-, 98-, and 81-bp fragments that are shared by all members of the classical M. mycoides cluster (Fig. 2B) .
The type strains of the species M. cottewii, M. putrefaciens, and M. yeatsii were also amplified under low-stringency conditions or with high template concentrations as with the PCR-LIF system. Only weak bands were observed on the gel after electrophoresis, and restriction of the amplicons would not result in clearly visible band patterns. As judged from the sequences of the type strains (accession no. U67945, U67946, and U26055), these three strains were expected to give a band pattern similar to that of the majority of the species in the classical M. mycoides cluster. The other control strains of M. bovigenitalium, M. bovirhinis, M. bovis, M. bovoculi, and M. canis were not amplified with the REAP primer pair.
Amplification of 1-l suspensions from the two dilution series of the cultured PG1 T strain resulted in detection levels of the PCR that correspond to 3 and 4 CFU per reaction, respectively. The PCR products were detected by agarose gel electrophoresis and ethidium bromide staining. However, these PCR products could not be seen on the agarose gel after restriction with AluI. Detection of M. mycoides SC after restriction of the amplicons was achieved in fractions containing 30 and 40 CFU/reaction, and the sensitivity was therefore estimated to be at least 30 copies of DNA per amplification reaction.
Analysis of specimens from cattle. Specimens from two Tanzanian cows with postmortem diagnoses of CBPP were analyzed by the two PCR assays ( Table 3 ). The samples consisted of pleural fluid applied to chromatography paper. DNA from the samples was eluted by heating the pieces of paper in a buffer as described in Materials and Methods. Amplification of the material by the PCR-LIF and PCR-REA systems showed that both samples were clearly positive for M. mycoides SC with either of the two systems. The method of preserving and sending noninfectious clinical samples on chromatography paper was shown to be cheap, convenient, and functional.
In another investigation we received and analyzed 13 pieces of chromatography paper which had been exposed to samples of various material from 11 different cows (Table 3) . Analysis by the PCR-LIF system gave a clear-cut result: five of the samples were positive for M. mycoides SC, and eight were negative (Fig. 3) . When analyzed by the PCR-REA system, the same five samples were positive by PCR, but only three of them proved to be M. mycoides SC after restriction. The other two samples contained too little DNA of each fragment size after the restriction procedure to be visible by ethidium bromide staining of the agarose gel. Therefore, the samples were reanalyzed by nested PCR in which a U1-U8 amplification preceded the amplification with REAP primers. Again, by nested PCR, the same five samples were positive for the M. mycoides cluster, and they were confirmed to be M. mycoides SC by REA, while the other eight samples were still negative for the M. mycoides cluster.
Analysis of lung tissue (Table 3 , specimen 16) by PCR-LIF resulted in the characteristic double peak, thus confirming the presence of M. mycoides SC in the lung. The disease of the animal was also diagnosed as CBPP upon postmortem examination.
DISCUSSION
Differentiation between M. mycoides SC, a highly important species in veterinary medicine, and its close relatives is a great need but also a challenging task. An outbreak of CBPP may require large-scale screening of samples in a short time. This emphasizes the need for well-designed diagnostic systems which combine different molecular biology techniques to attain high throughput as well as specificity and sensitivity of the tests. PCR is already known as a quick, sensitive, and specific method, but it involves a high risk of cross-contamination and carryover contamination, especially if nested PCR is used. We believe that the use of LIF for detection of the amplicons eliminates the need for nested PCR, thus saving time, diminishing the manual work, and most important, reducing the risk of contamination. Furthermore, it gives an accurate identification of the PCR product compared to that of an agarose gel. Gels can be reloaded for an increased capacity of analysis.
As revealed in this study, the specificity of the two diagnostic PCR systems may include not only members of the classical M. mycoides cluster but also species within the phylogenetic M. mycoides cluster. Amplification of M. cottewii, M. yeatsii, and M. putrefaciens was observed when the annealing temperature was lowered but also when the amount of template was substantial, as is the case for PCR on concentrated and heat-lysed mycoplasma culture. The resulting amount of PCR product was always less than the amount of PCR product produced from any species of the classical M. mycoides cluster. This can be explained by several mismatches between the reverse primers in both PCR systems and their corresponding target sequences in M. cottewii, M. yeatsii, and M. putrefaciens. Nevertheless, all strains of M. mycoides SC could clearly be discriminated by both systems, indicating their usefulness in the detection of this important organism.
Clinical samples may contain various PCR inhibitors that affect the yield of an amplification. For example, if the ratio of host DNA to mycoplasma DNA is high, there is a risk that the total amount of DNA in the sample that is needed for detection of the mycoplasma exceeds the amount that is functional with regard to the concentration of free magnesium ions in the PCR buffer. The problem with PCR inhibitors, despite a high sensitivity of the PCR, might be overcome by performing a nested PCR in order to increase the number of target molecules and dilute the inhibitors in the diagnostic PCR. Both diagnostic systems can easily be used in a nested fashion with the primers complementary to 16S rRNA regions U1 and U8 in the first amplification. As determined from the dilution series of a mycoplasma culture in logarithmic growth, the sensitivity of the PCR-LIF system corresponds to 0.3 to 0.4 CFU per PCR, which is approximately 100 times more sensitive than the PCR-REA system. Theoretically, it is excessive to perform nested PCR when the PCR-LIF system is used, while the analyses in this study showed that performing nested PCR improved the results obtained by PCR-REA in several cases.
Specimens of pleural fluid can be considered to contain only trace amounts of PCR-inhibitory substances, as judged from the strongly positive results obtained from some pleural-fluid samples. Furthermore, M. mycoides SC seems to be present in the pleural fluid of most infected cattle, which makes it a suitable specimen for PCR analysis. However, it is difficult to collect samples from suspected carrier animals in general, and sometimes also at the postmortem. M. mycoides SC may be completely sequestered and therefore absent in, e.g., nasal fluid and some parts of the lungs. Three of the lung samples that were found negative by PCR-LIF and PCR-REA came from animals that were seropositive for M. mycoides as shown by a complement fixation test and competitive ELISA (Table 3 , specimens 6, 7, and 9). This might be an example of cases where the sampling procedure rather than the diagnostic method causes misleading results. It is also possible that these animals had acquired immunity before they were acutely infected or that the infections were cured before the samples were taken.
It can always be questioned whether diagnostic systems involving group-specific amplification and differentiation based on single nucleotide substitutions are robust. In the PCR-LIF system, the differentiation is based on a 2-nucleotide sequence length difference between the two operons. An insertion or deletion in the amplified gene region would be detected in the electropherogram from the sequencer due to accurate size determination, and the species would still differ from the other members of the M. mycoides cluster. The detection of an aberrant amplicon would prompt further analysis by DNA sequencing of at least a part of the 16S rRNA genes in order to identify the species. In the restriction system, however, identification is based on a single nucleotide in one of the two 16S rRNA genes, which is found in a semiconserved region. DNA sequencing of 25 strains of M. mycoides SC which represent different IS1296 patterns and come from distant regions (Table  1) showed that new mutations in the 16S rRNA genes are extremely rare in this species. It is therefore reasonable to assume that relying on a single polymorphism for identification of M. mycoides SC is safe. A similar diagnostic system for identification of M. capricolum subsp. capripneumoniae (5, 24) has proved to be very robust despite a greater intraspecific variation in the 16S rRNA genes of this species (19) . The amplicon of the PCR-REA system contains the PstI restriction site that was used to identify M. capricolum subsp. capripneumoniae in the diagnostic system described by Ros Bascuñana et al. (24) . It is therefore possible to use the PCR-REA system for diagnosis of contagious caprine pleuropneumonia as well as for CBPP, by replacing the AluI enzyme with PstI. Digestion of the REAP amplicon with PstI resulted in two bands of 82 and 703 bp for all members of the M. mycoides cluster except M. capricolum subsp. capripneumoniae, where three bands of 82, 703, and 785 bp were formed (data not shown).
In conclusion, we have presented two alternative methods for diagnosis of CBPP based on PCR of the 16S rRNA genes. FIG. 3 . Fluorogram curves of 13 samples from 11 African cattle which were supplied on chromatography paper and subsequently analyzed by PCR-LIF. Specimen numbers correspond to those in Table 3 . NC, negative controls. All peaks at 100 and 200 bp are internal size standards. Samples 4, 5, 8, 10, and 15 were positive for M. mycoides SC, as shown by the characteristic double peak. The absence of peaks in the fluorogram curves of samples 3, 6, 7, 9, 11, 12, 13, and 14 showed that these were negative for the M. mycoides cluster.
Both systems were shown to identify M. mycoides SC in various types of samples.
